Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today a new research partnership ...
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...
ELEPHAS BIOSCIENCES RAISES $40M TO ACCELERATE COMMERCIALIZATION OF ITS LIVE TUMOR PROFILING PLATFORM
MADISON, Wis., Nov. 6, 2025 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tumor profiling platform for immunotherapy response ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Elephas Biosciences Corp. announced Tuesday the ...
People in almost any business must write from time to time, whether they like it or not. But whatever the project — like a marketer’s blog post, a business leader’s executive summary or a developer’s ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Learn more about: Elephas Biosciences Corp. Venture Investors ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Madison-based cancer ...
With the weather (hopefully!) due to change soon, you'll be ready for some cosy movie nights – so now is the perfect time to pick up a state-of-the-art home theatre projector. A projector will ...
A phase 1 first-in-human study of the novel anti-LLT1 antibody (ZM008) alone and in combination with anti-PD1 antibody in patients with advanced solid tumors. Phase II basket study to evaluate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results